A half-billion dollars later, Peninsula company goes SPAC route to roll out its AI-based heart test

The "blank-check" merger will create a company with $400 million to expand uptake of its heart disease test, save money for health care providers and lead to better diagnosis and treatment for patients.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news